Klinikum Rechts der Isar der Technischen Universitat Munchen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Klinikum Rechts der Isar der Technischen Universitat Munchen.The latest application filed is for "lymphotoxin alpha for use in therapy of myeloid leukemia".

Company Profile

5.20.21

Klinikum Rechts der Isar der Technischen Universitat Munchen - Munchen DE
Klinikum Rechts der Isar der Technischen Universitat Munchen - Munich DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Lymphotoxin Alpha For Use In Therapy Of Myeloid Leukemia App 20220193195 - Jost; Philipp J. ; et al.	2022-06-23
Combination treatment of pancreatic cancer Grant 11,351,156 - Guillermet-Guibert , et al. June 7, 2	2022-06-07
Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases Grant 10,987,345 - Bassermann , et al. April 27, 2	2021-04-27
Treatment of synucleinopathies Grant 10,918,628 - Hoglinger , et al. February 16, 2	2021-02-16
Treatment Of Tumors By A Combination Of An Oncolytic Adenovirus And A Cdk4/6 Inhibitor App 20210038661 - Holm; Per Sonne ; et al.	2021-02-11
Medical/Surgical Implant App 20210030528 - Hutmacher; Dietmar Werner ; et al.	2021-02-04
VSV/NDV hybrid viruses for oncolytic therapy of cancer Grant 10,906,942 - Ebert , et al. February 2, 2	2021-02-02
Medical/surgical implant Grant 10,799,336 - Hutmacher , et al. October 13, 2	2020-10-13
Implant for lymph node formation/regeneration Grant 10,736,987 - Kwak , et al. A	2020-08-11
Method for Assessing the Efficacy of IMIDS and Composition or Combination for Use in Treating IMID Sensitive Diseases App 20200016144 - Bassermann; Florian ; et al.	2020-01-16
Differential Diagnosis Of Eczema And Psoriasis App 20190316201 - EYERICH; Kilian ; et al.	2019-10-17
Molecular Sensor For Nmr/mri Based On Analyte-dependent Spectral Changes Of Temporarily Encapsulated Hyperpolarized 129xe App 20190307907 - WESTMEYER; GIL GREGOR ; et al.	2019-10-10
Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases Grant 10,398,688 - Bassermann , et al. Sep	2019-09-03
Diagnosis of multiple sclerosis Grant 10,345,298 - Hemmer , et al. July 9, 2	2019-07-09
Vsv/ndv Hybrid Viruses For Oncolytic Therapy Of Cancer App 20190153039 - EBERT; Oliver ; et al.	2019-05-23
Controlled activation of complement components for use as endogenous adjuvant Grant 10,238,735 - Bredehorst , et al.	2019-03-26
Tofacitinib As Vaccination Immune Modulator App 20190083609 - GUTERMUTH; Jan ; et al.	2019-03-21
Vaccination strategy Grant 10,195,267 - Knolle , et al. Fe	2019-02-05
Cannula and Instrument for Inserting a Catheter App 20180168683 - Nasseri; Mohammad Ali ; et al.	2018-06-21
Quantitative Assay For Heat Shock Proteins 70 (hsp70) Protein In Body Fluids App 20180017567 - MULTHOFF; Gabriele	2018-01-18
Implant for Lymph Node Formation/Regeneration App 20170354757 - Kwak; Min-Seok ; et al.	2017-12-14
Medical/Surgical Implant App 20170258574 - Hutmacher; Dietmar Werner ; et al.	2017-09-14
Means and methods for diagnosing and treating multiple sclerosis Grant 9,733,244 - Hemmer , et al. August 15, 2	2017-08-15
Diagnosis Of Multiple Sclerosis App 20170074877 - Hemmer; Bernhard ; et al.	2017-03-16
Differential Diagnosis Of Eczema And Psoriasis App 20170037476 - EYERICH; Kilian ; et al.	2017-02-09
Low Molecular Weight Immune-Modulators As Adjuvants for Specific Immunotherapy App 20160271257 - BREDEHORST; Reinhold ; et al.	2016-09-22
Means And Methods For Diagnosing And Treating Multiple Sclerosis App 20160161482 - Hemmer; Bernhard ; et al.	2016-06-09
Means and methods for diagnosing and treating multiple sclerosis Grant 9,297,809 - Hemmer , et al. March 29, 2	2016-03-29
Means And Methods For Diagnosing And Treating Multiple Sclerosis App 20140080156 - Hemmer; Bernhard ; et al.	2014-03-20
Modulation Of Effector T Cell Responses By Local Depletion Of Complement Component C3 App 20130337044 - Bredehorst; Reinhard ; et al.	2013-12-19
Controlled Activation Of Complement Components For Use As Endogenous Adjuvant App 20130337045 - Bredehorst; Reinhard ; et al.	2013-12-19

Company Registrations

CAGE Code

CM983

KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN DERMATOLOGIE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.